Betulinic acid

Catalog #
27739-2
$205 *
Size: 200 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Betulinic acid is a natural pentacyclic triterpenoid that selectively induces apoptosis in tumor cells by directly activating the mitochondrial pathway of apoptosis through a p53- and CD95-independent mechanism. Betulinic acid also displays TGR5 agonist activity (EC50 =1.04 µM). Betulinic acid is used to study its potential cardiovascular role in the modulation of endothelium-dependent relaxation. Betulinic acid displays anti-HIV and antitumor activity.

Synonyms
Lupatic acid; Betulic acid; Mairin; NSC113090; NSC-113090
Product Info
Storage and Usage
Citations
Formula
C30H48O3
MW
456.7 Da
Solubility
Soluble in DMSO
Biological Activity
Initially reported as a selective inhibitor of human melanoma, betulinic acid was found active against neuroectodermal (neuroblastoma, medulloblastoma, Ewing's sarcoma) and malignant brain tumors, ovarian carcinoma, in human leukemia HL-60 cells, and malignant head and neck squamous cell carcinoma SCC25 and SCC9 cell lines. In contrast, epithelial tumors, such as breast, colon, small cell lung and renal cell carcinomas, as well as T-cell leukemia cells, were completely unresponsive to treatment with betulinic acid.
CAS Registry #
472-15-1